Meet Sudoscan at the 62nd EASD Annual Meeting 2026
Sudoscan is pleased to announce its participation in the industry exhibition at the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD), which will take place from 28 September to 2 October 2026 at the Allianz MiCo – Milan Convention Centre in Milan, Italy.
The EASD Annual Meeting is a major international conference dedicated to the latest advances in diabetes research, treatment, and care. It will bring together thousands of delegates from around the world to share scientific knowledge, explore new developments, and discuss the future of diabetes management.
During the exhibition, the Impeto Medical team will welcome attendees at booth F11 from 29 September to 1 October 2026 to introduce Sudoscan and discuss its applications in the assessment of sudomotor function and peripheral autonomic neuropathies.
About the EASD Annual Meeting
The European Association for the Study of Diabetes encourages and supports research in the field of diabetes, promotes the rapid dissemination of scientific knowledge, and facilitates its application in clinical practice.
Its annual meeting provides an international platform for researchers, clinicians, healthcare professionals, and industry representatives to exchange knowledge and discover developments shaping diabetes science and care.
The EASD 2026 scientific programme will include:
- Hundreds of scientific presentations covering both basic and clinical diabetes research.
- Keynote lectures, symposia, and oral sessions presenting the latest research findings.
- Insights into emerging developments in diabetes treatment, management, and patient care.
- Opportunities to meet leading international experts and foster scientific collaboration and knowledge exchange.
Through this comprehensive programme, EASD 2026 will offer attendees an overview of current progress and future directions in diabetes research and clinical practice.
Sudoscan: A Fast, Scientific Approach to Neuropathy Screening
Sudoscan is a non-invasive medical device designed to assess sudomotor function by measuring Electrochemical Skin Conductance through stainless steel sensors placed under the hands and feet.
The test provides objective and quantitative results in less than three minutes, without requiring any special patient preparation.
Its main benefits include:
- Fast and patient-friendly assessment: The test is non-invasive, simple to perform, and completed within a few minutes.
- Objective and quantitative results: Sudoscan generates numerical values that support consistent evaluation and comparison over time.
- Easy integration into clinical workflows: The automated procedure requires limited operator intervention and can support both clinical practice and research.
- Patient follow-up: Sudoscan can be used to support the identification and monitoring of peripheral autonomic neuropathies.
In diabetology, Sudoscan provides healthcare professionals and researchers with an accessible method for assessing sudomotor function and investigating neuropathic complications associated with diabetes.
Visit Us at Booth F11
We invite diabetologists, endocrinologists, clinicians, podiatrists, researchers, and other healthcare professionals to visit the Impeto Medical team at booth F11 to:
- Discover how Sudoscan assesses sudomotor function through a fast and non-invasive test.
- Attend a live demonstration and experience the simplicity of the examination.
- Discuss the use of Sudoscan in diabetes care, neuropathy assessment, patient follow-up, and clinical research.
- Learn more about integrating Sudoscan into clinical and research workflows.
Join us at the Allianz MiCo – Milan Convention Centre, from 29 September to 1 October 2026 and meet our team at booth F11.
For registration, scientific programme details, venue information, and further updates, please visit the official EASD 2026 website.
We look forward to welcoming you to Milan!
